Are you Dr. Putcha?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
L235
Stanford, CA 94305Phone+1 650-862-6142
Summary
- Dr. Girish Putcha, MD is a pathologist in Stanford, California. He is currently licensed to practice medicine in California, Missouri, and South Carolina.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 2003 - 2007
Washington University in St. Louis School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2004 - 2026
MO State Medical License 2012 - 2022
SC State Medical License 2011 - 2017
Clinical Trials
- AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test Start of enrollment: 2018 Jan 12
Publications & Presentations
PubMed
- 96 citationsMachine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNANathan Wan, David E. Weinberg, Tzu-Yu Liu, Katherine E. Niehaus, Eric A. Ariazi
BMC Cancer. 2019-08-23 - 426 citationsJNK-Mediated BIM Phosphorylation Potentiates BAX-Dependent ApoptosisGirish V. Putcha, Siyuan Le, Stephan Frank, Cagri G. Besirli, Kim Clark
Neuron. 2003-06-19 - 170 citationsIntrinsic and extrinsic pathway signaling during neuronal apoptosis: lessons from the analysis of mutant mice.Girish V. Putcha, Charles A. Harris, Krista L. Moulder, Rachael M. Easton, Craig B. Thompson
The Journal of Cell Biology. 2002-04-29
Press Mentions
Research Shows the Clinical Benefits of Detecting Adenomas in Multi-Cancer Early Detection Tests That Screen for Colorectal CancerJune 7th, 2022- Freenome Shows Continued Leadership in Colorectal Cancer ResearchOctober 25th, 2021
- With Illumina Acquisition Pending, GRAIL Presents Multi-Cancer Detection TestJune 7th, 2021
- Join now to see all
